ARCHIVES

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

This article is from The Cancer Letter archive.

Vol. 20 No. 33 | August 19, 1994

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

March 27, 2009

Samuel Waksal Pleads Guilty To Tax Evasion

March 7, 2003

NIH Faces Cuts Under House, Senate, Administration Plans

May 19, 1995

Court Agreement Clears The Way For Human Gene Transplant Study

May 26, 1989

Continuing Progress Reported On Breast Cancer Treatment; Mammography Controversy Cooled

November 26, 1976

In Brief: Congress Sets NCI Rescission At $10.785 Million; Centers to Be Funded According To Priority Scores

June 12, 1981